Geistlich Pharma has entered an exclusive national distribution collaboration agreement with StimLabs in the US, focusing on the commercialisation of the former’s Advanced Wound...
TAE Life Sciences (TLS), a leader in developing boron neutron capture therapy (BNCT) technology and associated innovative boron target drugs, and Stella Pharma, the...
OrganOx, a medical technology company developing innovative solutions for organ preservation and eGenesis, a biotechnology company developing human-compatible organs for patients with organ failure,...
Biomendex is continuing the development of its fully synthetic and biodegradable bone graft material, Adaptos, to enable better outcomes for patients and surgeons.
Currently, Biomendex...
